Table of contents

Papers

• Natural history of dyspepsia (1 May, 2002)

  L Agréus
• Clinical and economic consequences of dyspepsia in the community (1 May, 2002)

  P Moayyedi, J Mason
• Role of endoscopy and biopsy in the work up of dyspepsia (1 May, 2002)

  G N J Tytgat
• Definitions of reflux disease and its separation from dyspepsia (1 May, 2002)

  J Dent
• Discussion I (1 May, 2002)
• Assessment of outcome in dyspepsia: has progress been made? (1 May, 2002)

  S J O Veldhuyzen van Zanten
• Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms?

  (1 May, 2002)

  S J O Veldhuyzen van Zanten, N J Talley, A L Blum, E Bolling-Sternevald, M Sundin, O Junghard
• Discussion II (1 May, 2002)
• Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data

  (1 May, 2002)

  F Bazzoli, L De Luca, P Pozzato, RM Zagari, S Fossi, L Ricciardiello, G Nicolini, D Berretti, E Roda
• The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies (1 May, 2002)

  N J Talley, K Lauritsen
• Approaches to uninvestigated dyspepsia (1 May, 2002)

  R H Jones
• Helicobacter pylori test and treat strategy for young dyspeptic patients: new data

  (1 May, 2002)

  P Moayyedi
• Management of uninvestigated dyspepsia: review and commentary (1 May, 2002)

  A Axon
• Discussion III (1 May, 2002)
• H₂ receptor antagonists and prokinetics in dyspepsia: a critical review

  (1 May, 2002)

  P Bytzer
• Use of antisecretory agents as a trial of therapy (1 May, 2002)

  M B Fennerty
• Management of reflux disease (1 May, 2002)

  J Dent
• Dyspepsia: management guidelines for the millennium (1 May, 2002)

  N J Talley
• Discussion IV (1 May, 2002)